The promise of cytokine antibody arrays in the drug discovery process

Expert Opinion on Therapeutic Targets

Volumn 9, Issue 3, 2005, Pages 601-615

  Huang, Ruo Pan ^a   Yang, Weimin ^a   Yang, Dongzi ^b   Flowers, Lisa ^a   Horowitz, Ira R ^a   Cao, Xuan ^a   Huang, Ruochun ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Antibody array; Cytokine; Drug discovery; Protein array

Indexed keywords

ADALIMUMAB; ALPHA TOCOPHEROL; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; APTAMER; CYTOKINE; CYTOKINE ANTIBODY; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; ETANERCEPT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLIXIMAB; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LENERCEPT; LERDELIMUMAB; LEUKOTRIENE B4; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULOTROPIN;

ATHEROSCLEROSIS; AUTISM; BRAIN DISEASE; BREAST CANCER; CELL DIFFERENTIATION; CELL SURVIVAL; CEREBRAL PALSY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DNA MICROARRAY; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY POLYCYSTIC DISEASE; MYCOSIS; OVARY CANCER; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT;

ANTIBODIES; CYTOKINES; DRUG EVALUATION, PRECLINICAL; HUMANS; IMMUNOASSAY; PROTEIN ARRAY ANALYSIS;

EID: 21244469102     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.9.3.601     Document Type: Review

References (81)

1. MOSMANN TR, FONG TA: Specific assays for cytokine production by T cells. J. Immunol. Methods (1989) 116(2):151-158.
2. HSIEH CS, HEIMBERGER AB, GOLD JS, O'GARRA A, MURPHY KM: Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc. Natl Acad. Sci. USA (1992) 89(13):6065-6069.
3. BARALDI-JUNKINS CA, BECK AC, ROTHSTEIN G: Hematopoiesis and cytokines. Relevance to cancer and aging. Hematol. Oncol. Clin. North Am. (2000) 14(1):45-61, viii.
4. GERARD C, ROLLINS BJ: Chemokines and disease. Nat. Immunol. (2001) 2(2):108-115.
5. ZAGURY D, GALLO RC: Anti-cytokine Ab immune therapy: present status and perspectives. Drug Discov. Today (2004) 9(2):72-81.
6. ICHINOSE M, BARNES PJ: Cytokine-directed therapy in asthma. Curr. Drug Targets Inflamm. Allergy (2004) 3(3):263-269.
7. ANDREAKOS ET, FOXWELL BM, BRENNAN FM, MAINI RN, FELDMANN M: Cytokines and anti-cytokine biologicals in autoimmunity: present and future. Cytokine Growth Factor Rev. (2002) 13(4-5):299-313.
8. ZAGURY D, LE BUANEC H, BIZZINI B, BURNY A, LEWIS G, GALLO RC: Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. Cytokine Growth Factor Rev. (2003) 14(2):123-137.
9. BARNES PJ: Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev. (2003) 14(6):511-522.
10. ANDREAKOS E: Targeting cytokines in autoimmunity: new approaches, new promise. Expert Opin. Biol. Ther. (2003) 3(3):435-447.
11. BALKWILL FR: Cytokine therapy of cancer. The importance of knowing the context. Eur. Cytokine Netw. (1994) 5(4):379-385.
12. BURKE F, RELF M, NEGUS R, BALKWILL F: A cytokine profile of normal and malignant ovary. Cytokine (1996) 8(7):578-585.
13. FOTI E, FERRANDINA G, MARTUCCI R et al.: IL-6, M-CSF and IAP cytokines in ovarian cancer: simultaneous assessment of serum levels. Oncology (1999) 57(3):211-215.
14. PLANTE M, RUBIN SC, WONG GY, FEDERICI MG, FINSTAD CL, GASTL GA: Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer (1994) 73(7):1882-1888.
15. NEGUS RP, BALKWILL FR: Cytokines in tumour growth, migration and metastasis. World J. Urol. (1996) 14(3):157-165.
16. FASCIANI A, D'AMBROGIO G, BOCCI G, LUISI S, ARTINI PG, GENAZZANI AR: Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology. Fertil. Steril. (2001) 75(6):1218-1221.
17. HASSAN MI, KASSIM SK, SAEDA L, LABAN M, KHALIFA A: Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue. Anti-Cancer Res. (1999) 19(6C):5657-5662.
18. DUAN Z, FELLER AJ, PENSON RT, CHABNER BA, SEIDEN MV: Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. Clin. Cancer Res. (1999) 5(11):3445-3453.
19. PENSON RT, KRONISH K, DUAN Z et al.: Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int. J. Gynecol. Cancer (2000) 10(1):33-41.
20. BAMBERGER ES, PERRETT CW: Angiogenesis in epithelian ovarian cancer. Mol. Pathol. (2002) 55(6):348-359.
21. SIECZKIEWICZ GJ, HUSSAIN M, KOHN EC: Angiogenesis and metastasis. Cancer Treat. Res. (2002) 107:353-381.
22. MORGAN E, VARRO R, Sepulveda H et al.: Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. (2004) 110(3):252-266.
23. CARSON RT, VIGNALI DA: Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods (1999) 227(1-2):41-52.
24. KELLAR KL, DOUGLASS JP: Multiplexed microsphere-based flow cytometric immunoassays for human cytokines. J. Immunol. Methods (2003) 279(1-2):277-285.
25. CHAN-HUI PY, STEPHENS K, WARNOCK RA, SINGH S: Applications of eTag trade mark assay platform to systems biology approaches in molecular oncology and toxicology studies. Clin. Immunol. (2004) 111(2):162-174.
26. TIAN H, CAO L, TAN Y et al.: Multiplex mRNA assay using electrophoretic tags for high-throughput gene expression analysis. Nucleic Acids Res. (2004) 32(16):e126.
27. BOCK C, COLEMAN M, COLLINS B et al.: Photoaptamer arrays applied to multiplexed proteomic analysis. Proteomics (2004) 4(3):609-618.
28. PETACH H, GOLD L: Dimensionality is the issue: use of photoaptamers in protein microarrays. Curr. Opin. Biotechnol. (2002) 13(4):309-314.
29. LEE M, WALT DR: A fiber-optic microarray biosensor using aptamers as receptors. Anal. Biochem. (2000) 282(1):142-146.
30. EKINS R, CHU F: Immunoassay and other ligand assays: present status and future trends. J. Int. Fed. Clin. Chem. (1997) 9(3):100-109.
31. EKINS R, CHU F: Multianalyte microspot immunoassay. The microanalytical 'compact disk' of the future. Ann. Biol. Clin. (Paris) (1992) 50(5):337-353.
32. EKINS RP: Ligand assays: from electrophoresis to miniaturized microarrays. Clin. Chem. (1998) 44(9):2015-2030.
33. SAVIRANTA P, OKON R, BRINKER A, WARASHINA M, EPPINGER J, GEIERSTANGER BH: Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. Clin. Chem. (2004) 50(10): 1907-1920.
34. HUANG RP: Simultaneous detection of multiple proteins with an array-based enzyme-linked immunosorbent assay (ELISA) and enhanced chemiluminescence (ECL). Clin. Chem. Lab. Med. (2001) 39(3):209-214.
35. HUANG RP: Detection of multiple proteins in an antibody-based protein microarray system. J. Immunol. Methods (2001) 255(1-2):1-13.
36. HUANG RP, HUANG R, FAN Y, LIN Y: Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal. Biochem. (2001) 294(1):55-62.
37. LIN Y, HUANG R, CAO X, WANG SM, SHI Q, HUANG RP: Detection of multiple cytokines by protein arrays from cell lysate and tissue lysate. Clin. Chem. Lab. Med. (2003) 41(2):139-145.
38. HUANG RP: Cytokine antibody arrays: a promising tool to identify molecular targets for drug discovery. Comb. Chem. High Throughput Screen (2003) 6(8):769-775.
39. HUANG RP: Cytokine protein arrays. Methods Mol. Biol. (2004) 278:215-232.
40. MENDOZA LG, MCQUARY P, MONGAN A, GANGADHARAN R, BRIGNAC S, EGGERS M: High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA). Biotechniques (1999) 27(4):778-6, 788.
41. WIESE R, BELOSLUDTSEV Y, POWDRILL T, THOMPSON P, HOGAN M: Simultaneous multianalyte ELISA performed on a microarray platform. Clin. Chem. (2001) 47(8):1451-1457.
42. KNIGHT PR, SREEKUMAR A, SIDDIQUI J et al.: Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis. Shock (2004) 21(1):26-30.
43. LI Y, SCHUTTE RJ, ABU-SHAKRA A, REICHERT WM: Protein array method for assessing in vitro biomaterial-induced cytokine expression. Biomaterials (2005) 26(10):1081-1085.
44. WOODBURY RL, VARNUM SM, ZANGAR RC: Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA. J. Proteome Res. (2002) 1(3):233-237.
45. SCHWEITZER B, ROBERTS S, GRIMWADE B et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. (2002) 20(4):359-365.
46. HUANG R, LIN Y, WANG CC et al.: Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res. (2002) 62(10):2806-2812.
47. HAAB BB, DUNHAM MJ, BROWN PO: Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. (2001) 2(2):RESEARCH0004.
48. LI Y, NATH N, REICHERT WM: parallel comparison of sandwich and direct label assay protocols on cytokine detection protein arrays. Anal. Chem. 75(19) 5274-5281.
49. SCHWEITZER B, WILTSHIRE S, LAMBERT J et al. Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc. Natl. Acad. Sci. USA (2000) 97(18): 10113-10119.
50. FIRE A, XU SQ: Rolling replication of short DNA circles. Proc. Natl. Acad. Sci. USA (1995) 92(10):4641-4645.
51. ZHANG DY, BRANDWEIN M, HSUIH TC, LI H: Amplification of target-specific, ligation-dependent circular probe. Gene (1998) 211(2):277-285.
52. THOMAS DC, NARDONE GA, RANDALL SK: Amplification of padlock probes for DNA diagnostics by cascade rolling circle amplification or the polymerase chain reaction. Arch. Pathol. Lab. Med. (1999) 123(12):1170-1176.
53. VARGAS DL, NASCIMBENE C, KRISHNAN C, ZIMMERMAN AW, PARDO CA: Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. (2004) 57(1):67-81.
54. LIN Y, HUANG R, CHEN L et al.: Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int. J. Cancer (2004) 109(4):507-515.
55. NICHOLS MT, GIDEY E, MATZAKOS T et al.: Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology (2004) 40(4):836-846.
56. TURTINEN LW, PRALL DN, BREMER LA, NAUSS RE, HARTSEL SC: Antibody array-generated profiles of cytokine release from THP-1 leukemic monocytes exposed to different amphotericin B formulations. Antimicrob. Agents Chemother. (2004) 48(2):396-403.
57. YAMASAKI M, KITAGAWA T, CHUJO H et al.: Physiological difference between free and triglyceride-type conjugated linoleic acid on the immune function of C57BL/6N mice. J. Agric. Food Chem. (2004) 52(11):3644-3648.
58. LIN Y, HUANG R, SANTANAM N, LIU Y, PARTHASARATHY S, HUANG R: Profiling of human cytokines in healthy individuals with vitamin E supplementation by antibody array. Cancer Lett. (2002) 187(1-2):17.
59. MARTOGLIO AM, TOM BD, STARKEY M, CORPS AN, CHARNOCK-JONES DS, SMITH SK: Changes in tumorigen. Mol. Med. (2000) 6(9):750-765.
60. ISMAIL RS, BALDWIN RL, FANG J et al.: Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res. (2000) 60(23):6744-6749.
61. WELSH JB, ZARRINKAR PP, SAPINOSO LM et al.: Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. USA (2001) 98(3):1176-1181.
62. SAWIRIS GP, SHERMAN-BAUST CA, BECKER KG, CHEADLE C, TEICHBERG D, MORIN PJ: Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res. (2002) 62(10):2923-2928.
63. KAUKOLA T, SATYARAJ E, PATEL DD et al.: Cerebral palsy is characterized by protein mediators in cord serum. Ann. Neurol. (2004) 55(2):186-194.
64. CELIS JE, GROMOV P, CABEZON T et al.: Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol. Cell. Proteomics (2004) 3(4):327-344.
65. POCKAJ BA, BASU GD, PATHANGEY LB et al.: Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann. Surg. Oncol. (2004) 11(3):328-339.
66. HUANG R, LIN Y, FLOWERS L, LISOUKOV H et al.: molecular profiling of cytokine levels in human ovarian cancer patients. 1, 23-32. 2004.
67. TADROS Y, RUIZ-DEYA G, CRAWFORD BE, THOMAS R, ABDEL-MAGEED AB: In vivo proteomic analysis of cytokine expression in laser capture-microdissected urothelial cells of obstructed ureteropelvic junction procured by laparoscopic dismembered pyeloplasty. J. Endourol. (2003) 17(5):333-336.
68. KINGSMORE SF, PATEL DD: Multiplexed protein profiling on antibody-based microarrays by rolling circle amplification. Curr. Opin. Biotechnol. (2003) 14(1):74-81.
69. HUANG L, ZHAO A, WONG F et al.: Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler. Thromb. Vasc. Biol. (2004) 24(10):1783-1788.
70. XU Y, KULKOSKYJ, ACHEAMPONG E, NUNNARI G, SULLIVAN J, POMERANTZ RJ: HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc. Natl. Acad. Sci. USA (2004) 101(18):7070-7075.
71. GIROUX M, DENIS F: Human CD1d-unrestricted NKT cells release chemokines upon Fas engagement. Blood (2004).
72. POTIAN JA, AVIV H, PONZIO NM, HARRISON JS, RAMESHWAR P: Vetolike activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. (2003) 171(7):3426-3434.
73. NELSON BF, GRIMSRUD TE, LILES MR, GOODMAN RM, CORN RM: Surface plasmon resonance imaging measurements of DNA and RNA hybridization adsorption onto DNA microarrays. Anal. Chem. (2001) 73(1):1-7.
74. PAWLAK M, SCHICK E, BOPP MA, SCHNEIDER MJ, OROSZLAN P, EHRAT M: Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics (2002) 2(4):383-393.
75. PEI R, CHENG Z, WANG E, YANG X: Amplification of antigen-antibody interactions based on biotin labeled protein-streptavidin network complex using impedance spectroscopy. Biosens. Bioelectron. (2001) 16(6):355-361.
76. WU G, DATAR RH, HANSEN KM, THUNDAT T, COTE RJ, MAJUMDAR A: Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nat. Biotechnol. (2001) 19(9):856-860.
77. HUANG R, LIN Y, SHI Q et al.: Enhanced protein profiling arrays with ELISA-based amplification for high-throughput molecular changes of tumor patients' plasma. Clin. Cancer Res. (2004) 10(2):598-609.
78. WANG Y, WU TR, CAI S, WELTE T, CHIN YE: Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol. Cell. Biol. (2000) 20(13):4505-4512.
79. SCHARPF R, GARRETT ES, HU J, PARMIGIANI G: Statistical modeling and visualization of molecular profiles in cancer. Biotechniques (2003) Suppl.:22-29.
80. OCHS MF, GODWIN AK: Microarrays n cancer: research and applications. Biotechniques (2003) Suppl.:4-15.
81. RINGNER M, PETERSON C: Microarray-based cancer diagnosis with artificial neural networks. Biotechiques (2003) Suppl.:30-35.